Pfizer submits data for third dose approval in US – ET HealthWorld

WASHINGTON: Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. Last week, the United States approved the booster shot of Pfizer-BioNTech and Moderna vaccines for people with weakened immune systems. Pfizer and BioNTech presented the results of their Phase One trial that evaluated the safety and efficacy of a third shot. “The data we’ve seen to date suggest a third dose of our vaccine elicits antibody levels…

Read More